Our purpose
The Accelerating Clinical Trials in the European Union (ACT EU) initiative supports smarter clinical trials through regulatory, technological and process innovation.
Our vision is to transform the EU into a region that supports clinical trial development and enables collaboration and innovation at all stages of the clinical research lifecycle.
Seamless coordination among stakeholders, regulators and ethics committees will lead to more cross-border collaboration.
The result will be better, more impactful clinical trials, benefitting patients and healthcare in Europe in the process.
Progress towards 2030 clinical trial targets
84 multinational clinical trials authorised in addition to the historical average* Goal: 500 extra multinational trials by the end of 2030
40.8% of trials recruit participants within 200 days from application submission* Goal: 66% by the end of 2030
